During the past 56 years, our product portfolio has grown significantly providing the foundation for the success of the company.

To sustain this in the future, the Board of Directors has committed to develop 21 new products per year and launch them in the global market as soon as they go off-patent.  Furthermore, a number of new research projects are under progress that will allow DEMO to become an innovative group of companies in the international pharmaceutical market.

For this reason, we have invested strongly in the creation and sourcing of our modern and high tech Research & Development laboratory.  DEMO’s R&D lab spans more than 4.000m2. It is equipped with the latest instruments and is staffed with the top graduates of the Universities of Greece.

Under the supervision of highly qualified researchers – most of whom own PhD degrees from the most acclaimed universities in Europe – our R&D lab represents the company’s launching pad for the following decades.

In order for our company to be successful in its international endeavors it was clear that we needed to build in-house expertise which would allow us to provide regulatory support to our partners worldwide.

Hence, in 2005 we established an independent Regulatory Affairs Department staffed with 21 full time regulatory officers charged with preparing files for submission and approval to the competent regulatory authorities worldwide.

Our products’ registration files are all in CTD (Common Technical Document) format, which allows us to quickly and efficiently proceed with submissions in multiple countries simultaneously.

Furthermore, our participation in national, mutual (MRP) and decentralized (DCP) registration processes worldwide have deemed our regulatory affairs department as one of the most competent, providing invaluable support to our partners globally. Last but not least, we have dedicated regulatory officers that constantly monitor local & regional regulatory conditions, providing immediate response in case there are any changes in local requirements.

Since the company’s establishment, the quality of our products has consistently been our top concern.

For this reason, throughout the company’s history, we have highly invested in the modernization and improvement of our production premises as well as our Quality Control Department.

As a result, all of our manufacturing premises use highly automated manufacturing procedures and are equipped with state-of-the-art technology certifications:

  • cGMP certified (current Good Manufacturing Practices)
  • ISO 9001:2008
  • ISO 13485:2003
  • ΙSO 14001:2015
  • ISO 45001:2018
  • DY8/1348/04

Moreover, our new Quality Control Laboratory conforms to the latest Good Laboratory Procedures and exceeds 4.000 m2.  It has been rated as one of the best in Europe and is fully equipped with state-of-the-art devices.  Furthermore, our long-time cooperation with both the Chemistry and Biology Departments of the University of Athens provides us with an unlimited pool of talent to draw from in order to staff our laboratories with best-in-class scientists.